Search

Search Constraints

You searched for: Author/Creator Sanchez, Eric

Search Results

3. Estimating a normal reference range for serum B‐cell maturation antigen levels for multiple myeloma patients. (22nd April 2020)

4. JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression. (18th August 2019)

6. Normalization of serum B‐cell maturation antigen levels predicts overall survival among multiple myeloma patients starting treatment. (22nd May 2020)

7. Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells. (June 2019)

8. The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker. (3rd April 2018)